Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

McMaster University

$90,000.00

Investigating local vs. systemic autoimmune pathomechanisms in complex airways disease

FY 2017-18

Summary
In autoimmune diseases, such as lupus and rheumatoid arthritis, our own body produces antibodies directed against our own cells. Though lung diseases, such as asthma and COPD are not considered to be autoimmune, there are some forms of vasculitis (with a known autoimmune component) that present with severe asthma. Recently, we have identified a subset of severe asthmatics with poor response to oral glucocorticosteroids (prednisone) to have autoantibodies in their sputum (and not blood). These patients vastly contribute to the socio-economic burden. In fact, the burden might increase because these autoantibodies might render the new 'expensive' monoclonal antibody treatments to be less effective/ineffective. Therefore, it is important to understand how these antibodies develop, why they develop, and how we can stop them from contributing to disease.
Program
CIHR Fellowship
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
376474
Name
Mukherjee Manali
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Investigating local vs. systemic autoimmune pathomechanisms in complex airways disease
Programtype2
Fellowship Programs
Orgnameinp2
McMaster University
Cihramount2
$90,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Anti-Neutrophil Cytoplasmic Antibodies; Autoantibodies; Autoimmunity; Eosinophilic Airways Disease; Eosinophilic Granulomatosis With Polyangiitis; Immunoglobulins; Severe Asthma; Sputum Biomarker
Abstract
In autoimmune diseases, such as lupus and rheumatoid arthritis, our own body produces antibodies directed against our own cells. Though lung diseases, such as asthma and COPD are not considered to be autoimmune, there are some forms of vasculitis (with a known autoimmune component) that present with severe asthma. Recently, we have identified a subset of severe asthmatics with poor response to oral glucocorticosteroids (prednisone) to have autoantibodies in their sputum (and not blood). These patients vastly contribute to the socio-economic burden. In fact, the burden might increase because these autoantibodies might render the new 'expensive' monoclonal antibody treatments to be less effective/ineffective. Therefore, it is important to understand how these antibodies develop, why they develop, and how we can stop them from contributing to disease.
Competitiondate
201711
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Mukherjee, Manali
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $90,000~ $0~
McMaster University - $90,000 Grant (2017-18) | Canada Spends